Seattle-area well being knowledge startup Truveta introduced a collaboration Tuesday with Boston Scientific, a number one medical gadget firm. The partnership will allow Boston Scientific researchers to entry Truveta’s de-identified knowledge from greater than 65 million U.S. sufferers, with the intention of gathering insights into gadgets and illness states. To indicate the worth of its strategy, Truveta additionally launched a preliminary evaluation of peripheral artery illness linking numerous remedies and gadgets with outcomes. Truveta additionally lately launched an outline of its findings on COVID-19, and added 4 new well being programs to its community, bringing the full to 24. Phrases of the take care of Boston Scientific weren’t disclosed.
See also Seagen inks deal with Dutch biotech to develop and commercialize drug candidate
Powered by Inline Related Posts